• 1. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 2. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 3. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 4. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 5. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Piperidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines

Cis-Piperidine-3,5-Diol;Hydrochloride: A Comprehensive Overview in Modern Chemical Biology

The compound CAS no. 1375204-12-8, specifically identified as cis-piperidine-3,5-diol;hydrochloride, represents a significant molecule in the realm of chemical biology and pharmaceutical research. This compound, characterized by its unique structural and chemical properties, has garnered considerable attention due to its potential applications in drug development and therapeutic interventions.

At the heart of its utility lies the piperidine core, a six-membered heterocyclic amine that forms the backbone of numerous bioactive molecules. The presence of hydroxyl groups at the 3 and 5 positions, combined with the salt form of hydrochloride, enhances its solubility and bioavailability, making it a promising candidate for various pharmacological applications. The stereochemistry of the cis configuration further influences its interactions with biological targets, contributing to its specificity and efficacy.

Recent advancements in chemical biology have highlighted the importance of piperidine derivatives in developing novel therapeutic agents. The compound cis-piperidine-3,5-diol;hydrochloride has been extensively studied for its role in modulating enzyme activity and receptor binding. For instance, research has demonstrated its potential in inhibiting certain kinases and phosphodiesterases, which are pivotal in regulating cellular signaling pathways. These findings underscore its significance in addressing various pathological conditions.

In the context of drug discovery, the structural features of cis-piperidine-3,5-diol;hydrochloride offer a versatile scaffold for medicinal chemists to design and optimize lead compounds. The hydroxyl groups provide opportunities for hydrogen bonding interactions, while the hydrochloride salt enhances stability and formulation flexibility. This combination has led to several innovative drug candidates entering preclinical and clinical trials.

The hydrochloride form of this compound is particularly noteworthy for its improved pharmacokinetic properties. The salt form increases water solubility, facilitating better absorption and distribution within the body. This characteristic is crucial for developing oral formulations that ensure consistent therapeutic levels. Additionally, the stability provided by the hydrochloride salt ensures that the compound remains effective throughout its shelf life.

One of the most exciting areas of research involving cis-piperidine-3,5-diol;hydrochloride is its potential in oncology. Studies have shown that derivatives of this compound can selectively target cancer cells by interfering with key metabolic pathways. By modulating enzymes such as PI3K and mTOR, it offers a promising approach to developing targeted therapies that minimize side effects associated with traditional chemotherapies.

The compound's ability to cross the blood-brain barrier has also opened new avenues in neuropharmacology. Researchers are exploring its potential in treating neurological disorders such as Alzheimer's disease and Parkinson's disease. The precise stereochemistry of cis-piperidine-3,5-diol;hydrochloride allows for selective interaction with neuronal receptors, suggesting its role in enhancing cognitive functions and mitigating neurodegenerative processes.

Emerging evidence also highlights the compound's anti-inflammatory properties. Chronic inflammation is a hallmark of numerous diseases, including autoimmune disorders and metabolic syndromes. By inhibiting inflammatory cytokines and enzymes, cis-piperidine-3,5-diol;hydrochloride demonstrates potential as an anti-inflammatory agent. This multifaceted therapeutic profile positions it as a valuable asset in developing comprehensive treatment strategies.

The synthesis and optimization of derivatives based on cis-piperidine-3,5-diol;hydrochloride continue to be an active area of investigation. Advances in synthetic methodologies have enabled chemists to modify its structure while retaining its core pharmacological properties. This flexibility has led to the development of several analogs with enhanced potency and reduced toxicity.

In conclusion, cis-piperidine-3,5-diol;hydrochloride (CAS no. 1375204-12-8) stands out as a versatile and promising compound in chemical biology and pharmaceutical research. Its unique structural features, combined with its favorable pharmacokinetic properties, make it an attractive candidate for developing novel therapeutics across multiple disease domains. As ongoing research continues to uncover new applications and mechanisms of action, this compound is poised to play a significant role in shaping future medical interventions.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)